$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
慢性髓细胞白血病治疗新药-博舒替尼
2025-10-19 11:44:20
Check Details
博舒替尼治疗慢性髓细胞白血病的效果
2025-10-19 11:44:20
Check Details
博舒替尼的治疗效果如何?
2025-10-19 11:44:20
Check Details
博舒替尼医保可以报销吗?
2025-10-19 11:44:20
Check Details
博舒替尼在哪买的到?
2025-10-19 11:44:20
Check Details
博舒替尼功效与作用
2025-10-19 11:44:20
Check Details
施达赛是哪个厂家的
2025-10-19 11:44:20
Check Details
施达赛医保怎么报销
2025-10-19 11:44:20
Check Details
施达赛达沙替尼什么价格
2025-10-19 11:44:20
Check Details
雷德帕斯(米哚妥林)多少钱一盒?
2025-10-19 11:44:20
Check Details
用米哚妥林多久会产生耐药性?
2025-10-19 11:44:20
Check Details
米哚妥林在医保范围内吗?
2025-10-19 11:44:20
Check Details
1
2
...
580
581
582
583
584
585
586
...
935
936
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Ponatinib vs. Olverembatinib: A Multidimensional Comparison of Third-Generation BCR-ABL Inhibitors
2
Avatrombopag (Doptelet): Oral TPO-RA for Multiple Thrombocytopenia Types
3
Gilteritinib (Xospata): Precision Oral Targeted Therapy for FLT3-Mutated AML
4
Belumosudil for Chronic Graft-Versus-Host Disease (cGVHD): Efficacy, Side Effects, and Patient Treatment Guide
5
Olutasidenib: Mechanism of Action and Clinical Guide for IDH1-Mutated AML
6
Gilteritinib: Efficacy, Medication Guide and Latest Advances for FLT3-Mutated AML
7
Common Adverse Reactions and Clinical Safety Management of Gilteritinib (Xospata)
8
Adverse Reaction Profile and Clinical Safety Management of Idelalisib
9
Clinical Significance of Platelet Recovery During Revumenib (Menin Inhibitor) Therapy
10
A Key Therapeutic Breakthrough Against T315I-Mutant CML
11
Tafasitamab: An Fc-Enhanced CD19-Targeted Immunotherapy for B-Cell Malignancies
12
Tafasitamab and Lenalidomide Combination Therapy Guide